Barbara M. Davit

Bioequivalence Requirements in the European Union: Critical Discussion

Jack A. Cook, Paul A. Dickinson, James E. Polli, 2012 .

Summary Workshop Report: Facilitating Oral Product Development and Reducing Regulatory Burden Through Novel Approaches to Assess Bioavailability/Bioequivalence

Francis X. Muller, Amitava Mitra, Jack A. Cook, 2012, AAPS Journal.

Incurred sample reanalysis in bioequivalence studies for abbreviated new drug applications.

Sriram Subramaniam, Barbara M. Davit, Ethan M. Stier, 2014, Bioanalysis.

Highly Variable Drugs: Observations from Bioequivalence Data Submitted to the FDA for New Generic Drug Applications

Lawrence X. Yu, Barbara M. Davit, Xiaojian Jiang, 2008, The AAPS Journal.

Utility of Physiologically Based Absorption Modeling in Implementing Quality by Design in Drug Development

Lawrence X. Yu, Robert A. Lionberger, Barbara M. Davit, 2011, The AAPS Journal.

PQRI Workshop Report: Application of IVIVC in Formulation Development

Anthony J. DeStefano, Sandra Suarez-Sharp, Maziar Kakhi, 2014 .

Dissolution Testing for Generic Drugs: An FDA Perspective

Lawrence X. Yu, Barbara M. Davit, Dale P. Conner, 2011, The AAPS Journal.